These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 17449961)

  • 41. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
    Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
    Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of intraductal papillary neoplasia of the biliary tract and pancreas.
    Kloek JJ; van der Gaag NA; Erdogan D; Rauws EA; Busch OR; Gouma DJ; ten Kate FJ; van Gulik TM
    Hum Pathol; 2011 Jun; 42(6):824-32. PubMed ID: 21292296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN.
    Siveke JT; Einwächter H; Sipos B; Lubeseder-Martellato C; Klöppel G; Schmid RM
    Cancer Cell; 2007 Sep; 12(3):266-79. PubMed ID: 17785207
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
    Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
    J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular signatures of pancreatic cancer.
    Hong SM; Park JY; Hruban RH; Goggins M
    Arch Pathol Lab Med; 2011 Jun; 135(6):716-27. PubMed ID: 21631264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precursors to invasive pancreatic cancer.
    Maitra A; Fukushima N; Takaori K; Hruban RH
    Adv Anat Pathol; 2005 Mar; 12(2):81-91. PubMed ID: 15731576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular pathogenesis of intraductal papillary mucinous neoplasms of the pancreas.
    Thosani N; Dasari CS; Bhutani MS; Raimondo M; Guha S
    Pancreas; 2010 Nov; 39(8):1129-33. PubMed ID: 20881900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions.
    Fischer CG; Wood LD
    J Pathol; 2018 Dec; 246(4):395-404. PubMed ID: 30105857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas.
    Wada K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
    Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH
    Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraductal papillary mucinous neoplasms of the pancreas: clinical surveillance and malignant progression, multifocality and implications of a field-defect.
    Remotti HE; Winner M; Saif MW
    JOP; 2012 Mar; 13(2):135-8. PubMed ID: 22406584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Precancerous lesions of the pancreas.
    Zamboni G; Hirabayashi K; Castelli P; Lennon AM
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):299-322. PubMed ID: 23809247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):280-5. PubMed ID: 16858538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. WHO-classification 2000: exocrine pancreatic tumors.
    Klöppel G; Lüttges J
    Verh Dtsch Ges Pathol; 2001; 85():219-28. PubMed ID: 11894402
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
    Katabi N; Klimstra DS
    J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas.
    Schoedel KE; Finkelstein SD; Ohori NP
    Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystic neoplasms of the exocrine pancreas.
    Campbell F; Azadeh B
    Histopathology; 2008 Apr; 52(5):539-51. PubMed ID: 17903202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
    J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.